Research Progress on Catalpol as Treatment for Atherosclerosis
Open Access
- 13 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 716125
- https://doi.org/10.3389/fphar.2021.716125
Abstract
Coronary atherosclerotic heart disease, cerebrovascular disease, and peripheral artery disease are common diseases with high morbidity and mortality rates and must be addressed. Their most frequent complications, including myocardial infarction and stroke, are caused by spontaneous thrombotic occlusion and are the most frequent cause of death worldwide. Atherosclerosis (AS) is the most widespread underlying pathological change for the above diseases. Therefore, drugs that interfere with this pathophysiological process must be incorporated in the treatment. Chinese traditional and herbal drugs can effectively treat AS. With the development of traditional Chinese medicine, the active ingredients in common Chinese medicinal materials must be thoroughly purified prior to their application in western medicine. Various proprietary Chinese medicine preparations with remarkable effects have been used in AS treatment. Catalpol, the active component of Rehmannia glutinosa, belongs to iridoid terpene and has anti-inflammatory, antioxidant, insulin resistance improvement, and other related effects. Several reviews have been conducted on this compound and its actions against osteoporosis, neurodegenerative diseases, Alzheimer's disease (AD), Parkinson's disease (PD) and diabetes and its complications. The current review focused on catalpol’s effect on atherosclerotic plaque formation in different animal models. The potential mechanisms of catalpol to ameliorate AS were also summarized in terms of oxidative stress, inflammation, cell aging, apoptosis, and activation of the silent information regulator factor 2-related enzyme 1 (SIRT1) pathway.Funding Information
- Science and Technology Department of Henan Province
This publication has 50 references indexed in Scilit:
- Dried Root of Rehmannia glutinosa Prevents Bone Loss in Ovariectomized RatsMolecules, 2013
- Homocysteine Inhibits Hepatocyte Proliferation via Endoplasmic Reticulum StressPLOS ONE, 2013
- Oxidative stress and endothelial dysfunction: Therapeutic implicationsAnnals of Medicine, 2011
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinThe New England Journal of Medicine, 2008
- Hyperhomocysteinemia Alters Cardiac Substrate Metabolism by Impairing Nitric Oxide Bioavailability Through Oxidative StressJournal of the American College of Cardiology, 2007
- Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human AtherosclerosisCirculation Research, 2006
- Shelterin: the protein complex that shapes and safeguards human telomeresGenes & Development, 2005
- The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transitionOncogene, 1998
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle CellsOnline Journal of Public Health Informatics, 1996